HHS responds to a report on autism and ancitaminophen: shots

Inna Kot/Getty Images/Stockphoto

The Trump administration plans to issue a report this month that would link the use of acetaminophen pain reliever (sold under the name of the Tilanol brand) during pregnancy, as well as some aspects of vitamins, to the autism spectrum disorder, although there is no scientific research to support these allegations.

This is just another controversy surrounding the actions of the Minister of Health and Humanitarian Services Robert F. Kennedy Junior, who repeated unaccounted allegations about autism in the past, promised to “reach the bottom” of her case.

The agency confirmed that it is working on a report, but it refused to comment on its conclusions. “Until we issue the final report, any claims about its contents are nothing more than speculation,” a HHS spokesman sent an email in a statement.

there There is no reliable scientific evidence That acetaminophen causes autism or that leuucovorin (derived from folic acid) can prevent disorder, as the HHS report claims, according to reporting reports Wall Street Journal.

In fact, those in the medical community, including the Association of Mother’s Medicine, said in a statement that acetaminophen is safe and recommended for use during pregnancy, especially for the treatment of fever and pain. The community said in its statement, “Incredible fever, especially in the first trimester of pregnancy, increases the risk of miscarriage, birth defects, premature birth, and inappropriate pain that can lead to mother depression, anxiety and high blood pressure.”

“It is a deceptive and misleading order to boil the reasons for autism into one simple thing,” said Dr. Alicia Halladai, the chief science official at the Autism Foundation. There are hundreds of genes associated with autism, and although there are also other complicated environmental factors, the institution says, “Any association between acetaminophen and autism depends on limited, conflicting, inactive sciences and prematurely, given the current science.”

A few studies It suggested that there is a fetal exposure to the fetus to the asymaminophen and the risk of diagnosis with ASD disorder (ADHD). but The biggest study so farThe cooperation funded by the National Institutes of Health between us and the Swedish scientists, did not find any increasing danger.

Even before the publication of that study in 2024, a local local court reached a similar conclusion If the product is responsible.

Yokovorin, also known as phonic acid, is a form of vitamin B9 (also known as folate) that is used to treat certain types of vitamin B9 deficiency, which is usually caused by chemotherapy for cancer. It is sometimes described outside the designation as a treatment for autism, although the evidence as working is minimal.

The use of Leucovorin depends on research This indicates that many people with autism have a metabolic difference that can reduce the amount of folic acid that reaches the brain. Leucovorin seems to provide a road around the metaphor.

Folic acid is important for the development of the brain and nervous system, which is why pregnant women are often described as specific supplements that contain folic acid, which is an artificial version of folic acid. The lack of folic acid in the mother increases the risk of neuromus defects including evil -like, but the association with autism is unclear.

In its statement, the Foundation of Autism said that there are four studies that indicate that low folate levels in pregnant women can increase the risk of autism, but she said, “This science is still in very early stages, and more studies are necessary before reaching a final conclusion.”

Leave a Comment